mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.008 |